Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.

@article{Westermaier2010ProphylacticIM,
  title={Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.},
  author={Thomas Westermaier and Christian Stetter and Giles H. Vince and Mirko Pham and Jose Manuel Perez Tejon and Joerg Eriskat and Ekkehard Kunze and C Matthies and Ralf-Ingo Ernestus and L{\'a}szl{\'o} Solymosi and Klaus Roosen},
  journal={Critical care medicine},
  year={2010},
  volume={38 5},
  pages={
          1284-90
        }
}
OBJECTIVE To examine whether the maintenance of elevated magnesium serum concentrations by intravenous administration of magnesium sulfate can reduce the occurrence of cerebral ischemic events after aneurysmal subarachnoid hemorrhage. DESIGN Prospective, randomized, placebo-controlled study. SETTING Neurosurgical intensive care unit of a University hospital. INTERVENTIONS One hundred ten patients were randomized to receive intravenous magnesium sulfate or to serve as controls. Magnesium… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-2 OF 2 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 34 REFERENCES

Calcium antagonists for aneurysmal subarachnoid haemorrhage.

  • The Cochrane database of systematic reviews
  • 2002
VIEW 10 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…